Literature DB >> 29318432

The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.

A L Valentini1, M Miccò1, B Gui2, M Giuliani1, E Rodolfino1, A M Telesca1, T Pasciuto3, A Testa3, M A Gambacorta4, G Zannoni5, V Rufini6, A Giordano6, V Valentini4, G Scambia3, R Manfredi1.   

Abstract

OBJECTIVES: To analyse the role of DW-MRI in early prediction of pathologically-assessed residual disease in locally-advanced cervical cancer (LACC) treated with neoadjuvant chemoradiotherapy followed by radical surgery.
METHODS: Between October 2010-June 2014, 108 women with histologically-proven cervical cancer were screened; 88 were included in this study. Tumour volume (TV) and ADCmean were measured before (baseline-MRI) and after 2 weeks of chemoradiotherapy (early-MRI). According to histopathology, treatment response was classified as complete (CR) or partial (PR). Comparisons were made with Mann-Whitney, Wilcoxon and χ2 tests. ROC curves were generated for statistically significant parameters on univariate analysis.
RESULTS: CR and PR were documented in 40 and 48 patients. At baseline-MRI, TV did not differ between groups. At early-MRI, TV was higher in PR than in CR (p=0.001). ΔTV reduction after treatment was lower in PR than in CR (63.6% vs. 81.1%; p=0.001). At baseline-MRI and early-MRI, ADCmean did not differ between PR and CR. ROC curve showed best cut-off for predicting pathological PR was ΔTV reduction of 73% with sensitivity, specificity, accuracy, NPV, PPV of 73%, 72.5%, 72.7%, 76%, 69%.
CONCLUSIONS: TV evaluated before and early after treatment could predict pathological response in LACC. ADCmean did not correlate with treatment outcome. KEY POINTS: • Early-MRI tumour volume assessment could predict pathological response to nCRT in LACC. • Best cut-off for predicting pathological PR was ΔTV reduction of 73 %. • Early-MRI ADC mean measurements did not correlate with treatment outcome.

Entities:  

Keywords:  Chemoradiotherapy · Diffusion magnetic resonance imaging; Magnetic resonance imaging; Tumour volume; Uterine cervical neoplasms

Mesh:

Year:  2018        PMID: 29318432     DOI: 10.1007/s00330-017-5233-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

1.  New standard of care for cervical cancer sets stage for next questions.

Authors:  C McNeil
Journal:  J Natl Cancer Inst       Date:  1999-03-17       Impact factor: 13.506

2.  Carcinoma of the cervix uteri.

Authors:  J L Benedet; F Odicino; P Maisonneuve; U Beller; W T Creasman; A P Heintz; H Y Ngan; M Sideri; S Pecorelli
Journal:  J Epidemiol Biostat       Date:  2001

3.  Value of apparent diffusion coefficient (ADC) in assessing radiotherapy and chemotherapy success in cervical cancer.

Authors:  Zhan-Zhao Fu; Yong Peng; Li-Yan Cao; Yan-Sheng Chen; Kun Li; Bao-Hong Fu
Journal:  Magn Reson Imaging       Date:  2015-02-07       Impact factor: 2.546

4.  Morphological effects of radiochemotherapy on cervical carcinoma: a morphological study of 50 cases of hysterectomy specimens after neoadjuvant treatment.

Authors:  Gian Franco Zannoni; Valerio Gaetano Vellone; Arnaldo Carbone
Journal:  Int J Gynecol Pathol       Date:  2008-04       Impact factor: 2.762

Review 5.  The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know.

Authors:  Evis Sala; Andrea G Rockall; Susan J Freeman; Donald G Mitchell; Caroline Reinhold
Journal:  Radiology       Date:  2013-03       Impact factor: 11.105

6.  The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.

Authors:  Fei Kuang; Ziping Yan; Jian Wang; Ziyuan Rao
Journal:  Magn Reson Imaging       Date:  2013-12-27       Impact factor: 2.546

7.  Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study.

Authors:  Valerio Gallotta; Gabriella Ferrandina; Vito Chiantera; Anna Fagotti; Francesco Fanfani; Alfredo Ercoli; Francesco Legge; Barbara Costantini; Salvatore Gueli Alletti; Carolina Bottoni; Luigi Pedone Anchora; Camilla Nero; Giovanni Scambia
Journal:  J Minim Invasive Gynecol       Date:  2015-04-28       Impact factor: 4.137

8.  The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.

Authors:  Chun Fu; Dujun Bian; Fengying Liu; Xiaoyan Feng; Wanping Du; Xiangquan Wang
Journal:  Int J Gynecol Cancer       Date:  2012-07       Impact factor: 3.437

9.  Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.

Authors:  Vanessa N Harry; Scott I Semple; Fiona J Gilbert; David E Parkin
Journal:  Gynecol Oncol       Date:  2008-09-06       Impact factor: 5.482

10.  Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.

Authors:  Li Zhu; Lijing Zhu; Hua Shi; Huanhuan Wang; Jing Yan; Baorui Liu; Weibo Chen; Jian He; Zhengyang Zhou; Xiaofeng Yang; Tian Liu
Journal:  BMC Cancer       Date:  2016-02-10       Impact factor: 4.430

View more
  7 in total

1.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

2.  The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study.

Authors:  Vittoria Rufini; Angela Collarino; Maria Lucia Calcagni; Guido Maria Meduri; Valentina Fuoco; Tina Pasciuto; Antonia Carla Testa; Gabriella Ferrandina; Maria Antonietta Gambacorta; Maura Campitelli; Benedetta Gui; Gianfranco Zannoni; Riccardo Manfredi; Giovanni Scambia; Alessandro Giordano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-14       Impact factor: 9.236

Review 3.  Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.

Authors:  Sharareh Sanei Sistani; Fateme Parooie; Morteza Salarzaei
Journal:  Contrast Media Mol Imaging       Date:  2021-03-02       Impact factor: 3.161

Review 4.  Implications of the new FIGO staging and the role of imaging in cervical cancer.

Authors:  Aki Kido; Yuji Nakamoto
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

Review 5.  Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy.

Authors:  Petra J van Houdt; Yingli Yang; Uulke A van der Heide
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244

6.  The role of apparent diffusion coefficient (ADC) in the evaluation of lymph node status in patients with locally advanced cervical cancer: our experience and a review.

Authors:  Benedetta Gui; Luca Russo; Laura Minordi; Maura Miccò; Salvatore Persiani; Giacomo Avesani; Vittoria Rufini; Valentina Fuoco; Rosa Autorino; Gabriella Ferrandina; Giovanni Scambia; Riccardo Manfredi
Journal:  Pol J Radiol       Date:  2022-08-10

7.  Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.

Authors:  Benedetta Gui; Rosa Autorino; Maura Miccò; Alessia Nardangeli; Adele Pesce; Jacopo Lenkowicz; Davide Cusumano; Luca Russo; Salvatore Persiani; Luca Boldrini; Nicola Dinapoli; Gabriella Macchia; Giuseppina Sallustio; Maria Antonietta Gambacorta; Gabriella Ferrandina; Riccardo Manfredi; Vincenzo Valentini; Giovanni Scambia
Journal:  Diagnostics (Basel)       Date:  2021-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.